The Indian government has imposed a minimum import price on crucial pharmaceutical ingredients like penicillin G, amoxicillin, and 6-APA. T...

The government has proposed to impose MIP on Penicillin-G (Pen-G), with possible extension to 6-aminopenicillanic acid (6-APA) and amoxicil...

Pharma experts have flagged concerns over the government’s plan to set minimum import prices (MIP) for key drug ingredients such as Penicil...

India is setting a minimum import price for essential drug ingredients. This move aims to shield local manufacturers from cheap imports, pa...

The Rs 2,400 crore Pen-G plant is expected to start trial production in April and commercial production in a couple of months and the rampi...

Union Budget 2023: The multiple initiatives announced clearly reflect the government’s intent to address the malaise. However, on-the-groun...

The two Indians are, however, still alive in the first Grand Slam of the season as they will compete in the mixed doubles.

Energy stocks added nearly 1.5% - their best session in a week - as oil prices jumped on signs of U.S. supply tightness.

The attachment to devices and the constant use of technology is associated with higher stress levels, researchers found.

The ‘rollback’ advance pricing agreement (APA) was signed between a US multinational and the tax department at about 6 pm on Monday.

The government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers.

A government proposal to slap anti-dumping duties on Chinese and Mexican imports of two key pharma ingredients will push up the prices of c...

The small pharmaceutical industry is opposed to imposition of safeguard duty on import of antibiotic bulk drugs 6APA and erythromycin from ...

Government is planning to start investigations into imports of 6APA and erythromycin- raw materials used for making antibiotics- from China.

The pharmaceutical sector-an area largely insulated from the downturn-is attracting companies from other sectors.

Australia’s takeover regulator has scuttled an A$11 billion ($9 billion) bid for Qantas Airways after refusing on Sunday to allow late supp...

The panel rejected an application by the bid group, Airline Partners Australia (APA).